News

Small Changes Count in Type 2 Diabetes Patients

Publish date: October 6, 2011

 

FROM THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES

Dr. Heintjes reported having no conflicts of interest. Her employer, PHARMO, however, receives funding from numerous pharmaceutical companies, including Astra Zeneca, which sponsored the current study.

Pages

Recommended Reading

ARB, CCB Both Help Prevent Events in Hypertensive Diabetes Patients
MDedge Cardiology
Atrial Fib Ups Early Death Risk in Women
MDedge Cardiology
CABG Outcomes Support More Liberal Blood Glucose Range
MDedge Cardiology
Statin Cuts Recurrent Stroke Risk Similarly in Diabetic, Nondiabetic Patients
MDedge Cardiology
Diabetes Linked to Carotid Artery Thickness in Young Adults
MDedge Cardiology
Continuous Glucose Monitor Accurate Post-Cardiac Surgery
MDedge Cardiology
DPP-4 Inhibitors May Be Cardioprotective
MDedge Cardiology
U.S. Diabetes-Free Life Expectancy on the Decline
MDedge Cardiology
Heart Failure Doubles 5-Year Fracture Risk
MDedge Cardiology
GAD Vaccine for Type 1 Diabetes Shows Continued Promise
MDedge Cardiology